DUOTETHER

Live / Applied — Extension of time to oppose received (as of 14 Sept 2026)

What this means for you

Not registered yet, but its 17 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
99501085
Mark type
Word mark
Filed
17 Nov 2025
Published for opposition
18 Aug 2026
Attorney of record
Christina M. Licursi

Goods and services

  • Class 001 — Chemicals: mRNA for use in the manufacture of vaccines and pharmaceuticals
  • Class 005 — Pharmaceuticals: mRNA therapeutic vaccines; mRNA therapeutic pharmaceuticals for the treatment of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo skeletal and genitourinary systems, and viruses and infectious diseases
  • Class 040 — Treatment of materials: Custom manufacture of mRNA vaccines and pharmaceuticals
  • Class 042 — Scientific and technological services: Research and development of mRNA vaccines and pharmaceuticals; scientific research and technological consultancy services in the field of analysis and production of mRNA therapy

Owner

Board proceedings on this mark

Prosecution history

  • 14 Sept 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
  • 18 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 18 Aug 2026 — PUBLISHED FOR OPPOSITION
  • 12 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 24 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 22 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 22 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 22 Jul 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 22 Apr 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 22 Apr 2026 — NON-FINAL ACTION E-MAILED
  • 22 Apr 2026 — NON-FINAL ACTION WRITTEN
  • 24 Mar 2026 — ASSIGNED TO EXAMINER
  • 19 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 17 Nov 2025 — APPLICATION FILING RECEIPT MAILED
  • 17 Nov 2025 — NEW APPLICATION ENTERED

View this trademark record on Rightsy